ADL is a PCR-focused testing lab certified to use specimens collected from humans, and in the first half of 2021 boasted $6.3 million in revenue. The investment from EKF is expected to fund more equipment and personnel.
The acquisition will be complete once ADL’s certificate of merger is acknowledged by the Texas secretary of state, EKF said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
